fluorouracil has been researched along with navitoclax in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajani, JA; Chen, Q; Honjo, S; Jin, J; Johnson, RL; Liu, B; Ma, L; Scott, A; Skinner, HD; Song, S; Wei, S; Zhu, H | 1 |
| Gotoh, N; Igarashi, K; Karasawa, T; Kato, Y; Kuzumaki, N; Narita, M; Otsuka, M; Sagara, A | 1 |
2 other study(ies) available for fluorouracil and navitoclax
| Article | Year |
|---|---|
ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer.
Topics: Adaptor Proteins, Signal Transducing; Aniline Compounds; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Esophageal Neoplasms; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Mice, Nude; Microscopy, Confocal; Neoplastic Stem Cells; Phosphoproteins; Proteomics; Signal Transduction; SOX9 Transcription Factor; Sulfonamides; Transcription Factors; Wnt Signaling Pathway; Xenograft Model Antitumor Assays; YAP-Signaling Proteins | 2015 |
Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR.
Topics: Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Celecoxib; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Resistance, Neoplasm; Female; Fluorouracil; Gene Expression; Humans; Minor Histocompatibility Antigens; NF-kappa B; Nitriles; Protein Interaction Maps; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Messenger; RNA, Small Interfering; Sulfonamides; Sulfones | 2016 |